RGEN
Repligen Corporation
Stock
$181.70+4.47 (+2.52%)Close Oct 2, 2026
- Capital expenditures, 2025
- $24M
- YoY, 2025
- −8.4%
- 5-year CAGR
- +0.9%
- 10-year CAGR
- +24.5%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $24M | −8.4% |
| 2024 | $26M | −29.1% |
| 2023 | $36M | −57.3% |
| 2022 | $85M | +26.4% |
| 2021 | $67M | +198.8% |
| 2020 | $22M | +21.4% |
| 2019 | $19M | +74.0% |
| 2018 | $11M | +95.0% |
| 2017 | $5.5M | +26.1% |
| 2016 | $4.3M | +64.6% |
| 2015 | $2.6M | −53.1% |
| 2014 | $5.6M | +20.9% |
| 2013 | $4.6M | +266.8% |
| 2012 | $1.3M | — |
| 2011 | $525K | −12.2% |
| 2010 | $597K | — |